Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis

Japanese Journal of Cancer Research

Volumn 87, Issue 4, 1996, Pages 349-356

  Ohnishi, Masami ^a   Tanaka, Takuji ^a   Makita, Hiroki ^a   Kawamori, Toshihiko ^a   Mori, Hideki ^a   Satoh, Kumiko ^b   Hara, Akira ^b   Murakami, Akira ^c   Ohigashi, Hajime ^d   Koshimizu, Koichi ^c  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

1 Acetoxychavicol acetate; 4 NQO; Oral carcinogenesis; Rat; Xanthine oxidase inhibitor

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; 4 NITROQUINOLINE 1 OXIDE; ANTINEOPLASTIC AGENT; BROXURIDINE; ENZYME INHIBITOR; PLANT EXTRACT; POLYAMINE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CELL LABELING; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CHROMOSOME NOR; CONTROLLED STUDY; DRUG STRUCTURE; DYSPLASIA; HYPERPLASIA; LABELING INDEX; MALE; MOUTH CANCER; NONHUMAN; ORAL DRUG ADMINISTRATION; PRECANCER; PRIORITY JOURNAL; RAT; SILVER STAINING; TONGUE CANCER;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTICARCINOGENIC AGENTS; BIOGENIC POLYAMINES; BROMODEOXYURIDINE; CARCINOGENS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MOUTH MUCOSA; NUCLEOLUS ORGANIZER REGION; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; SILVER STAINING; TERPENES; TONGUE; TONGUE NEOPLASMS; XANTHINE OXIDASE;

EID: 0029942709     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00229.x     Document Type: Article

References (42)

1. Parkin, D. M., Pisani, P. and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
2. La Vecchia, C., Lucchini, F., Negri, E., Boyle, O. and Levi, F. Trends on cancer mortality, 1955-1989: Asia, Africa and Oceania. Eur. J. Cancer, 29A, 2168-2211 (1993).
3. American Cancer Society. "I. Cancer Facts and Figures - 1992" (1992). American Cancer Society, Atlanta, GA.
4. La Vecchia, C., Franceschi, S., Levi, F., Lucchini, F. and Negri, E. Diet and human oral carcinoma in Europe. Oral Oncol., Eur. J. Cancer, 29B, 17-22 (1993).
5. Smith, C. J. Oral cancer and precancer: background, epidemiology and aetiology. Br. Dent. J., 167, 377-383 (1989).
6. Wray, A. and McGuirt, W. F. Smokeless tobacco usage associated with oral carcinoma. Arch. Otolaryngol. Head Neck Surg., 119, 929-933 (1993).
7. Slaughter, D. P., Southwick, H. W. and Smejkal, W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer, 6, 963-968 (1953).
8. Hong, W. K., Lippman, S. M. and Wolf, G. T. Recent advances in head and neck cancer: larynx preservation and cancer chemoprevention. The Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 53, 5113-5120 (1993).
9. Kotwall, C., Razack, M. S., Sako, K. and Rao, U. Multiple primary cancers in squamous cell cancer of the head and neck. J. Surg. Oncol., 40, 97-99 (1989).
10. Wattenberg, L. W. Chemoprevention of cancer by naturally occurring and synthetic compounds, In "Cancer Chemoprevention," ed. L. W. Wattenberg, M. Lipkin, C. W. Boone and G. J. Kelloff, pp. 19-39 (1992). CRC Press, Boca Raton, FL.
11. Moon, T. E. and Micozzi, M. S. ed. "Nutrition and Cancer Prevention: Investigating the Role of Micronutrients," pp. 1-588 (1989). Marcel Dekker, Inc., New York.
12. Micozzi, M. S. and Moon, T. E. ed. "Macronutrients: Investigating Their Role in Cancer," pp. 1-477 (1992). Marcel Dekker, Inc., New York.
13. Wattenberg, L. W. Inhibition of carcinogenesis by minor anutrient constituents of the diet. Proc. Nutr. Soc., 49, 173-183 (1990).
14. Tanaka, T. Cancer chemoprevention by natural products (Review). Oncol Rep., 1, 1139-1155 (1994).
15. Tanaka, T. Chemoprevention of oral carcinogenesis. Oral Oncol., Eur. J. Cancer, 31B, 3-15 (1995).
16. Kahl, R. The dual role of antioxidants in the modification of chemical carcinogenesis. J. Environ. Sci. Health, 4C, 47-92 (1986).
17. Guyton, K. Z. and Kensler, T. W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull., 49, 523-544 (1993).
18. Cerutti, P. A. Oxy-radicals and cancer. Lancet, 344, 862-863 (1994).
19. Parks, D. A. and Granger, D. N. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol. Scand., 548 (Suppl.), 87-99 (1986).
20. McCord, J. M. and Fridovich, I. The reduction of cytochrome C by milk xanthine oxidase. J. Biol. Chem., 243, 5753-5760 (1968).
21. Chang, W.-S., Lee, Y.-J., Lu, F.-J. and Chiang, H.-C. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res., 13, 2165-2170 (1993).
22. Wei, H., Bowen, R., Cai, Q., Barnes, S. and Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208, 124-130 (1995).
23. Klaunig, J. E. Chemopreventive effects of green tea components on hepatic carcinogenesis. Prev. Med., 21, 510-519 (1992).
24. Mitsui, S., Kobayashi, S., Nagahori, H. and Ogiso, A. Constituents from seeds of Alpinia galanga WILD. and their anti-ulcer activities. Chem. Pharm. Bull., 24, 2377-2382 (1976).
25. Noro, T., Sekiya, T., Katoh, M., Oda, Y., Miyase, T., Kuroyanagi, M., Ueno, A. and Fukushima, S. Inhibitors of xanthine oxidase from Alpinia galanga. Chem. Pharm. Bull., 36, 244-248 (1988).
26. Pence, B. C. and Reiners, J. J. J. Murine epidermal xanthine oxidase activity: correlation with degree of hyperplasia induced by tumor promoters. Cancer Res., 47, 6388-6392 (1987).
27. Kondo, A., Ohigashi, H., Murakami, A., Suratwadee, J. and Koshimizu, K. 1′-Acetoxychavicol acetate as a potent inhibitor of tumor promoter-induced Epstein-Barr virus activation from Languas galanga, a traditional Thai condiment. Biosci. Biotechnol. Biochem., 57, 1344-1345 (1993).
28. Kokoglu, E., Belce, A., Ozyurt, E. and Tepeler, Z. Xanthine oxidase levels in human brain tumors. Cancer Lett., 50, 179-181 (1990).
29. Reiners, J. J. J., Thai, G., Rupp, T. and Cantu, A. R. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoyl-phorbol-13-acetate and throughout the ontogeny of skin cancer. Part I. Quantitation of superoxide dismutase, catalase, glutathione peroxidase and xanthine oxidase. Carcinogenesis, 12, 2337-2343 (1991).
30. Tanaka, T., Makita, H., Ohnishi, M., Hirose, Y., Wang, A., Mori, H., Satoh, K., Hara, A. and Ogawa, H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of β-carotene. Cancer Res., 54, 4653-4659 (1994).
31. Deschner, E. E., Ruperto, J., Wong, G. and Newmark, H. L. Quercetin and rutin as inhibitors of azoxymethane-induced colonic neoplasia. Carcinogenesis, 12, 1193-1196 (1991).
32. Nunoshiba, T. and Demple, B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res., 53, 3250-3252 (1993).
33. Murakami, A., Nakamura, Y., Koshimizu, K. and Ohigashi, H. Studies on the mechanisms of 1′-acetoxychavicol acetate underlying its cancer preventive effect. Proc. Jpn. Cancer Assoc. 54th Annu. Meet., 139 (1995).
34. Bánóczy, J. and Csiba, A. Occurrence of epithelial dysplasia in oral leukoplakia. Oral Surg., 42, 766-774 (1976).
35. WHO. WHO Collaborating Center for oral precancerous lesions: definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg., 46, 518-539 (1978).
36. Koide, T., Sakai, S., Kawada, Y., Hara, A. and Sawada, H. Detection of polyamines by a new enzymatic differential assay. (7) Fundamental study on a new enzymatic differential assay of tissue polyamines. Acta Urol. Jpn., 36, 1103-1108 (1990) (in Japanese).
37. Tanaka, T., Kojima, T., Okumura, A., Yoshimi, N. and Mori, H. Alterations of the nucleolar organizer regions during 4-nitroquinoline 1-oxide-induced tongue Carcinogenesis in rats. Carcinogenesis, 12, 329-333 (1991).
38. Tanaka, T., Kojima, T., Morishita, Y. and Mori, H. Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Jpn. J. Cancer Res., 83, 835-842 (1992).
39. Tanaka, T., Kawamori, T., Ohnishi, M., Okamoto, K., Mori, H. and Hara, A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res., 54, 2359-2365 (1994).
40. Cohen, S. M. and Ellwein, L. B. Cell proliferation in carcinogenesis. Science, 249, 1007-1011 (1990).
41. Sugimura, T., Okabe, K. and Endo, K. The metabolism of 4-nitroquinoline 1-oxide. 3. An enzyme catalyzing the conversion of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in rat liver and hepatoma. Cancer Res., 26, 1717-1721 (1966).
42. Bailleul, B., Daubersies, P., Galiègue-Zouitina, S. and Loucheux-Lefebvre, M.-H. Molecular basis of 4-nitroquinoline 1-oxide carcinogenesis. Jpn. J. Cancer Res., 80, 691-697 (1989).